Recurrent Skin Carcinoma
5 clinical trials · Condition
◉ Watch Recurrent Skin Carcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer (NCT02964559) | Emory University | 2017-01-27 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer (NCT02318771) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-02-05 |
| Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer (NCT01727076) | National Cancer Institute (NCI) | 2013-02-15 |
| Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer (NCT00954226) | M.D. Anderson Cancer Center | 2009-08-05 |
Track Recurrent Skin Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.